Document is current
Any future updates will be listed below
-
Authors
Brenner, Darren M. https://orcid.org/0000-0002-8732-3632
Sharma, Amol
Rao, Satish S. C.
Laitman, Adam P.
Heimanson, Zeev
Allen, Christopher
Sayuk, Gregory S.
-
Funding
Funding for this research was provided by:
Salix Pharmaceuticals (study, analyses, technical editorial assistance)
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 21 December 2023
First Online: 9 April 2024
Declarations
:
: DMB is a consultant and speaker for Salix Pharmaceuticals and is supported in research by an unrestricted gift from the IDP Foundation. AS served on advisory boards for Ironwood Pharmaceuticals, Phathom Pharmaceuticals, Salix Pharmaceuticals, and Takeda Pharmaceuticals, and is supported in research by a grant from Vibrant Ltd. SSCR has served on the advisory boards for Ironwood Pharmaceuticals, Medtronic, Salix Pharmaceuticals, Sanofi Pharmaceuticals, Takeda Pharmaceuticals, and Vibrant Ltd. APL, ZH, and CA are employees of Salix Pharmaceuticals. GSS is a consultant and speaker for AbbVie/Ironwood Pharmaceuticals and Salix Pharmaceuticals and is a consultant for the GI Health Foundation
: Each trial received institutional review board approval and was conducted in accordance with the ethical principles of the Declaration of Helsinki, and all patients provided written informed consent.
